NASDAQ:IOSP - Innospec Stock Price, Price Target & More

Get Started

$74.95 -0.45 (-0.60 %)

(As of 05/25/2018 04:00 PM ET)

Previous Close$75.40

Today's Range$74.50 - $75.47

52-Week Range$54.10 - $79.90

Volume71,776 shs

Average Volume117,629 shs

Market Capitalization$1.86 billion

P/E Ratio16.11

Dividend Yield2.31%

Beta1.03

About Innospec (NASDAQ:IOSP)

Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals for use as fuel additives, ingredients for personal care, home care, agrochemical, mining and other applications, and oilfield chemicals worldwide. It operates through four segments: Fuel Specialties, Performance Chemicals, Oilfield Services, and Octane Additives. The Fuel Specialties segment offers a range of specialty chemical products used as additives in various fuels. This segment's products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. The Performance Chemicals segment provides technology-based solutions for its customers' processes or products focused in the personal care, home care, agrochemical, and mining markets. The Oilfield Services segment develops and markets products to prevent loss of mud in drilling operations; chemical solutions for fracturing, stimulation, and completion operations; and products for oil and gas production, which enable flow assurance and asset integrity. The Octane Additives segment produces and sells tetra ethyl lead (TEL) for use in automotive gasoline. This segment is also involved in an environmental remediation business that manages the cleanup of redundant TEL plants. The company serves oil and gas exploration and production companies, oil refineries, fuel manufacturers and users, formulators of personal care and home care, agrochemical and mining formulations, and other chemical and industrial companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado.

Receive IOSP News and Ratings via Email

Sign-up to receive the latest news and ratings for IOSP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Chemicals & allied products

Sub-IndustrySpecialty Chemicals

SectorBasic Materials

SymbolNASDAQ:IOSP

CUSIP45768S10

Webwww.innospecinc.com

Phone303-792-5554

Debt

Debt-to-Equity Ratio0.24

Current Ratio2.13

Quick Ratio1.28

Price-To-Earnings

Trailing P/E Ratio16.11

Forward P/E Ratio17.03

P/E GrowthN/A

Sales & Book Value

Annual Sales$1.31 billion

Price / Sales1.40

Cash Flow$6.7220 per share

Price / Cash11.15

Book Value$33.80 per share

Price / Book2.22

Profitability

EPS (Most Recent Fiscal Year)$4.66

Net Income$61.80 million

Net Margins4.86%

Return on Equity14.91%

Return on Assets8.37%

Miscellaneous

Employees1,900

Outstanding Shares24,400,000

Innospec (NASDAQ:IOSP) Frequently Asked Questions

What is Innospec's stock symbol?

Innospec trades on the NASDAQ under the ticker symbol "IOSP."

How often does Innospec pay dividends? What is the dividend yield for Innospec?

Innospec announced a semiannual dividend on Wednesday, May 9th. Stockholders of record on Monday, May 21st will be paid a dividend of $0.44 per share on Thursday, May 31st. This represents a dividend yield of 1.18%. The ex-dividend date is Friday, May 18th. This is a boost from Innospec's previous semiannual dividend of $0.39. View Innospec's Dividend History.

How were Innospec's earnings last quarter?

Innospec (NASDAQ:IOSP) released its earnings results on Tuesday, May, 8th. The specialty chemicals company reported $1.02 earnings per share for the quarter, beating the consensus estimate of $0.91 by $0.11. The specialty chemicals company had revenue of $360.70 million for the quarter, compared to analyst estimates of $308.90 million. Innospec had a return on equity of 14.91% and a net margin of 4.86%. The business's revenue was up 22.6% on a year-over-year basis. During the same period in the previous year, the company posted $1.00 EPS. View Innospec's Earnings History.

When is Innospec's next earnings date?

Innospec is scheduled to release their next quarterly earnings announcement on Tuesday, August, 14th 2018. View Earnings Estimates for Innospec.

What price target have analysts set for IOSP?

3 analysts have issued 1-year target prices for Innospec's stock. Their forecasts range from $65.00 to $65.00. On average, they anticipate Innospec's share price to reach $65.00 in the next year. View Analyst Ratings for Innospec.

Who are some of Innospec's key competitors?

Some companies that are related to Innospec include Olin (OLN), W. R. Grace and (GRA), Ashland (ASH), Univar (UNVR), Ingevity (NGVT), Balchem (BCPC), GCP Applied Technologies (GCP), PQ Group (PQG), KMG Chemicals (KMG), Innophos (IPHS), Nexeo Solutions (NXEO), OCI Partners (OCIP), Hawkins (HWKN), Liquidmetal Technologies (LQMT) and Gulf Resources (GURE).

Who are Innospec's key executives?

Innospec's management team includes the folowing people:

Mr. Patrick S. Williams, Pres, CEO & Director (Age 53)
Mr. Ian P. Cleminson, Exec. VP & CFO (Age 52)
Dr. Philip J. Boon, COO & Exec. VP (Age 59)
Dr. Ian M. McRobbie, Chief Technology Officer and Sr. VP of Research & Technology (Age 69)
Mr. Brian R. Watt, Sr. VP of Corp. Devel. & Investor Relations (Age 59)

Has Innospec been receiving favorable news coverage?

News coverage about IOSP stock has trended somewhat positive this week, Accern Sentiment reports. The research group identifies positive and negative press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Innospec earned a media sentiment score of 0.18 on Accern's scale. They also gave press coverage about the specialty chemicals company an impact score of 44.78 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

Who are Innospec's major shareholders?

Innospec's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (15.03%), Dimensional Fund Advisors LP (6.01%), Wells Fargo & Company MN (4.58%), Champlain Investment Partners LLC (3.39%), Northern Trust Corp (2.01%) and Westwood Holdings Group Inc. (1.63%). Company insiders that own Innospec stock include Brian Watt, Catherine Hessner, David Earl Williams, Hugh Aldous, Ian Cleminson, Ian Malcolm Mcrobbie, Joachim Roeser, Milton C Blackmore, Patrick Williams, Philip Curran and Philip John Boon. View Institutional Ownership Trends for Innospec.

Which institutional investors are selling Innospec stock?

IOSP stock was sold by a variety of institutional investors in the last quarter, including Principal Financial Group Inc., Principal Financial Group Inc., Millennium Management LLC, American Century Companies Inc., Thrivent Financial for Lutherans, Opus Capital Group LLC, Virginia Retirement Systems ET AL and First Wilshire Securities Management Inc.. Company insiders that have sold Innospec company stock in the last year include Brian Watt, Catherine Hessner, David Earl Williams, Hugh Aldous, Ian Cleminson, Milton C Blackmore, Patrick Williams, Philip Curran and Philip John Boon. View Insider Buying and Selling for Innospec.

Which institutional investors are buying Innospec stock?

IOSP stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Dean Investment Associates LLC, Dimensional Fund Advisors LP, Wells Fargo & Company MN, Champlain Investment Partners LLC, WBI Investments Inc., Westwood Holdings Group Inc. and Hsbc Holdings PLC. View Insider Buying and Selling for Innospec.

How do I buy shares of Innospec?

Shares of IOSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Innospec's stock price today?

One share of IOSP stock can currently be purchased for approximately $74.95.

How big of a company is Innospec?

Innospec has a market capitalization of $1.86 billion and generates $1.31 billion in revenue each year. The specialty chemicals company earns $61.80 million in net income (profit) each year or $4.66 on an earnings per share basis. Innospec employs 1,900 workers across the globe.

How can I contact Innospec?

Innospec's mailing address is 8310 SOUTH VALLEY HIGHWAY SUITE 350, ENGLEWOOD CO, 80112. The specialty chemicals company can be reached via phone at 303-792-5554 or via email at [email protected]

MarketBeat Community Rating for Innospec (IOSP)

Community Ranking:		2.4 out of 5 ( )
Outperform Votes:		131 (Vote Outperform)
Underperform Votes:		137 (Vote Underperform)
Total Votes:		268

MarketBeat's community ratings are surveys of what our community members think about Innospec and other stocks. Vote "Outperform" if you believe IOSP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IOSP will underperform the S&P 500 over the long term. You may vote once every thirty days.

Innospec (NASDAQ:IOSP) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

3 Wall Street analysts have issued ratings and price targets for Innospec in the last 12 months. Their average twelve-month price target is $65.00, suggesting that the stock has a possible downside of 13.28%. The high price target for IOSP is $65.00 and the low price target for IOSP is $65.00. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Hold	Hold
Consensus Rating Score:	2.67	2.67	2.33	2.33
Ratings Breakdown:	0 Sell Rating(s) 1 Hold Rating(s) 2 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 1 Hold Rating(s) 2 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 2 Hold Rating(s) 1 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 2 Hold Rating(s) 1 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$65.00	$65.00	$65.00	$65.00
Price Target Upside:	13.28% downside	12.75% downside	3.35% downside	3.35% downside

Innospec (NASDAQ:IOSP) Consensus Price Target History

Price Target History for Innospec (NASDAQ:IOSP)

Innospec (NASDAQ:IOSP) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/24/2018	Johnson Rice	Upgrade	Accumulate ➝ Buy		Medium
11/9/2017	Monness Crespi & Hardt	Downgrade	Buy ➝ Neutral		N/A
11/9/2017	KeyCorp	Reiterated Rating	Overweight		N/A
8/5/2016	CJS Securities	Upgrade	Market Perform ➝ Outperform	$63.00	N/A

(Data available from 5/25/2016 forward)

Innospec (NASDAQ:IOSP) Earnings History and Estimates Chart

Earnings by Quarter for Innospec (NASDAQ:IOSP)

Innospec (NASDAQ:IOSP) Earnings Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q2 2018	1	$1.11	$1.11	$1.11
Q3 2018	1	$0.96	$0.96	$0.96
Q4 2018	1	$1.31	$1.31	$1.31

Innospec (NASDAQ IOSP) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
8/6/2018		$1.10					N/A
5/8/2018	Q1 2018	$0.91	$1.02	$308.90 million	$360.70 million	View	Listen
2/13/2018	Q4 2017	$1.13	$1.47		$353.80 million	View	Listen
11/7/2017	Q3 2017	$0.85	$1.00	$309.40 million	$332.40 million	View	N/A
8/8/2017	Q2 2017	$1.08	$1.16		$326.30 million	View	Listen
5/9/2017	Q1 2017	$0.86	$1.00	$287.00 million	$294.30 million	View	Listen
2/14/2017	Q4 2016	$0.89	$1.09	$231.70 million	$237.80 million	View	N/A
11/2/2016	Q316	$0.77	$0.78	$232.15 million	$205.50 million	View	N/A
8/2/2016	Q2	$0.88	$1.03	$230.30 million	$228.00 million	View	Listen
5/3/2016	Q1	$0.77	$0.93	$252.15 million	$212.10 million	View	N/A
2/16/2016	Q4	$1.02	$1.24	$262.20 million	$246.00 million	View	Listen
11/3/2015	Q3	$0.87	$1.45	$262.70 million	$254.20 million	View	N/A
8/4/2015	Q215	$0.73	$1.02	$258.15 million	$242.90 million	View	N/A
5/5/2015	Q115	$0.84	$0.91	$270.20 million	$269.20 million	View	N/A
2/17/2015	Q414	$0.88	$1.16	$277.80 million	$290.70 million	View	N/A
11/4/2014	Q3	$0.72	$0.80	$228.40 million	$228.20 million	View	Listen
8/5/2014	Q2	$0.72	$0.75	$216.90 million	$221.30 million	View	Listen
5/6/2014	Q1	$0.67	$0.60	$222.50 million	$220.70 million	View	Listen
2/13/2014	Q413	$0.96	$1.06	$250.00 million	$241.60 million	View	Listen
11/6/2013	Q313	$0.83	$0.65	$199.60 million	$192.80 million	View	Listen
8/7/2013	Q2 2013	$0.68	$0.75	$190.40 million	$185.00 million	View	N/A
5/6/2013	Q1 2013	$0.85	$0.72	$208.20 million	$199.40 million	View	N/A
2/12/2013	Q4 2012	$0.85	$0.94			View	N/A
10/31/2012	Q3 2012	$0.81	$0.65			View	N/A
8/8/2012	Q2 2012	$0.84	$0.65			View	N/A
5/7/2012	Q1 2012	$0.90	$1.03			View	N/A
2/14/2012	Q4 2011	$0.85	$0.84			View	N/A
11/1/2011	Q3 2011		$0.93			View	N/A
8/8/2011	Q2 2011		$1.11			View	N/A
5/9/2011	Q1 2011		$0.91			View	N/A
2/15/2011	Q4 2010		$1.07			View	N/A
11/1/2010	Q3 2010		$0.75			View	N/A
8/3/2010	Q2 2010	$0.26	$0.29			View	N/A
5/6/2010	Q1 2010		$0.67			View	N/A
2/16/2010	Q4 2009	($0.26)	$0.55			View	N/A
10/29/2009	Q3 2009	$0.24	$0.46			View	N/A
8/4/2009	Q2 2009	$0.06	$0.31			View	N/A
5/6/2009	Q1 2009	$0.23	$0.32			View	N/A
2/19/2009	Q4 2008	$0.24	$0.23			View	N/A
10/30/2008	Q3 2008	$0.23	$0.22			View	N/A
7/30/2008	Q2 2008	$0.40	$0.19			View	N/A
4/30/2008	Q1 2008	$0.37	$0.36			View	N/A
2/7/2008	Q4 2007	$0.28	$0.50			View	N/A

(Earnings results data provided by Zacks Investment Research)

Innospec (NASDAQ:IOSP) Dividend Information

Innospec pays an annual dividend of $1.76 per share, with a dividend yield of 2.35%. IOSP's next semiannual dividend payment will be made on Thursday, May 31. Innospec pays out 37.77% of its earnings out as a dividend.

Next Dividend:	5/31/2018
Annual Dividend:	$1.76
Dividend Yield:	2.35%
Payout Ratio(s):	37.77% (Trailing 12 Months of Earnings) 40.00% (Based on This Year's Estimates) 37.85% (Based on Next Year's Estimates) 26.18% (Based on Cash Flow)

Dividend Payments by Quarter for Innospec (NASDAQ:IOSP)

Innospec (NASDAQ:IOSP) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/9/2018	semiannual	$0.44	1.18%	5/18/2018	5/21/2018	5/31/2018
11/8/2017	semiannual	$0.39	1.12%	11/15/2017	11/16/2017	11/27/2017
5/10/2017	semiannual	$0.38	1.2%	5/18/2017	5/22/2017	5/31/2017
11/3/2016	semiannual	$0.34	1.23%	11/10/2016	11/15/2016	11/24/2016
5/4/2016	semiannual	$0.33	1.37%	5/12/2016	5/16/2016	5/25/2016
11/4/2015	semiannual	$0.31	1.08%	11/12/2015	11/16/2015	11/25/2015
5/6/2015	semiannual	$0.30	1.36%	5/14/2015	5/18/2015	5/27/2015
11/5/2014	semiannual	$0.28	1.29%	11/13/2014	11/17/2014	11/26/2014
5/7/2014	semiannual	$0.27	1.27%	5/15/2014	5/19/2014	5/28/2014
11/5/2013		$0.50		11/14/2013	11/18/2013	11/27/2013
11/6/2013	semiannual	$0.05	0.22%	11/14/2013	11/18/2013	11/27/2013

(Data available from 1/1/2013 forward)

Innospec (NASDAQ IOSP) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.02%
Institutional Ownership Percentage: 91.80%

Insider Trading History for Innospec (NASDAQ:IOSP)

Institutional Ownership by Quarter for Innospec (NASDAQ:IOSP)

Innospec (NASDAQ IOSP) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/24/2018	Brian Watt	VP	Sell	3,500	$75.32	$263,620.00	26,349
5/22/2018	Hugh Aldous	Director	Sell	1,687	$76.72	$129,426.64	20,705
5/14/2018	Philip Curran	Insider	Sell	2,000	$73.63	$147,260.00	4,218
3/15/2018	Philip John Boon	VP	Sell	3,558	$69.69	$247,957.02	31,000
3/7/2018	Philip Curran	Insider	Sell	1,268	$68.24	$86,528.32	2,998
2/26/2018	Catherine Hessner	VP	Sell	1,382	$68.24	$94,307.68	27,518
2/23/2018	David Earl Williams	Insider	Sell	3,142	$68.54	$215,352.68	16,676
2/23/2018	Ian Cleminson	CFO	Sell	2,261	$68.55	$154,991.55	26,685
2/21/2018	Philip John Boon	VP	Sell	501	$67.04	$33,587.04	35,439
11/30/2017	Ian Cleminson	CFO	Sell	5,000	$71.67	$358,350.00	22,997
11/29/2017	Milton C Blackmore	Director	Sell	977	$73.67	$71,975.59	6,977
11/28/2017	Catherine Hessner	VP	Sell	707	$71.56	$50,592.92	25,791
11/28/2017	Ian Cleminson	CFO	Sell	515	$71.56	$36,853.40	28,878
11/28/2017	Philip Curran	Insider	Sell	375	$71.56	$26,835.00	2,968
11/24/2017	Philip Curran	Insider	Sell	1,352	$71.05	$96,059.60
11/22/2017	Patrick Williams	CEO	Sell	15,000	$71.49	$1,072,350.00	174,242
11/21/2017	Brian Watt	VP	Sell	440	$70.17	$30,874.80	30,730
9/7/2017	Milton C Blackmore	Director	Buy	442	$54.75	$24,199.50	6,000
3/17/2017	Patrick Williams	CEO	Sell	3,000	$63.01	$189,030.00	200,265
2/17/2017	Catherine Hessner	VP	Sell	3,664	$70.91	$259,814.24	30,705
2/17/2017	Ian Cleminson	CFO	Sell	5,157	$70.91	$365,682.87	31,470
12/6/2016	Milton C Blackmore	Director	Sell	1,089	$68.35	$74,433.15	6,647
11/22/2016	Ian Malcolm Mcrobbie	VP	Sell	20,614	$66.27	$1,366,089.78	42,543
11/18/2016	Hugh Aldous	Director	Sell	672	$63.15	$42,436.80	15,060
11/16/2016	Brian Watt	VP	Sell	3,000	$61.30	$183,900.00	32,089
11/14/2016	Joachim Roeser	Director	Sell	8,333	$60.53	$504,396.49	8,120
11/11/2016	Patrick Williams	CEO	Sell	17,342	$60.04	$1,041,213.68	196,926
3/16/2016	Patrick Joseph Mcduff	EVP	Sell	489	$43.05	$21,051.45
3/2/2016	Catherine Hessner	VP	Sell	1,455	$43.80	$63,729.00	30,983
2/29/2016	Patrick Joseph Mcduff	EVP	Sell	5,540	$43.56	$241,322.40	1,966
2/23/2016	Ian Cleminson	CFO	Sell	1,527	$43.72	$66,760.44	28,116
2/23/2016	Patrick Williams	CEO	Sell	2,066	$43.72	$90,325.52	207,217
12/4/2015	Martin Demora Hale	Director	Sell	10,000	$57.13	$571,300.00	181,480
11/30/2015	Patrick Williams	CEO	Sell	12,800	$58.42	$747,776.00	187,242
11/23/2015	Brian Watt	VP	Sell	3,000	$57.47	$172,410.00	34,644
11/18/2015	Ian Malcolm Mcrobbie	VP	Sell	10,156	$57.30	$581,938.80	40,889
11/18/2015	Patrick Joseph Mcduff	EVP	Sell	8,025	$57.50	$461,437.50
6/2/2015	Philip John Boon	VP	Sell	13,000	$43.04	$559,520.00
5/11/2015	Catherine Hessner	VP	Sell	5,000	$44.03	$220,150.00
3/10/2015	David Earl Williams	Insider	Sell	5,060	$43.14	$218,288.40
3/4/2015	Brian Watt	VP	Sell	3,000	$44.14	$132,420.00
3/2/2015	Patrick Williams	CEO	Sell	7,338	$45.12	$331,090.56
2/24/2015	Ian Cleminson	CFO	Sell	5,092	$43.90	$223,538.80
2/24/2015	Ian Malcolm Mcrobbie	VP	Sell	3,060	$43.90	$134,334.00
2/24/2015	Philip Curran	Insider	Sell	1,375	$43.90	$60,362.50
12/1/2014	Hugh Aldous	Director	Buy	1,000	$42.96	$42,960.00
8/15/2014	Hugh Aldous	Director	Buy	1,590	$40.41	$64,251.90
2/25/2014	Patrick Williams	CEO	Sell	4,800	$43.67	$209,616.00
2/18/2014	Ian Cleminson	CFO	Sell	4,819	$44.26	$213,288.94
11/20/2013	Ian Malcolm Mcrobbie	VP	Sell	15,000	$45.11	$676,650.00
8/29/2013	Philip John Boon	VP	Sell	1,923	$41.22	$79,266.06
5/22/2013	Mark Bracewell	Insider	Sell	1,060	$41.02	$43,481.20
5/9/2013	Catherine Hessner	VP	Sell	5,277	$40.69	$214,721.13
5/9/2013	Mark Bracewell	Insider	Sell	4,051	$40.69	$164,835.19
3/6/2013	Ian Malcolm Mcrobbie	VP	Sell	2,886	$41.69	$120,317.34
2/15/2013	Mark Bracewell	Insider	Sell	1,260	$41.19	$51,899.40

(Data available from 1/1/2013 forward)

Innospec (NASDAQ IOSP) News Headlines

Source:

Date	Headline
	Innospec (IOSP) VP Sells $263,620.00 in Stock www.americanbankingnews.com - May 25 at 1:20 PM
	Innospec (IOSP) Director Hugh Aldous Sells 1,687 Shares www.americanbankingnews.com - May 23 at 10:20 AM
	Innospec Initiates Site Construction for DRA Manufacturing www.zacks.com - May 22 at 9:16 AM
	Innospec starts construction of new site to make drag reducing agents seekingalpha.com - May 21 at 4:27 PM
	Innospec Breaks Ground on New Site for Manufacture of Drag Reducing Agents (DRA) finance.yahoo.com - May 21 at 9:15 AM
	Innospec (IOSP) Upgraded at Zacks Investment Research www.americanbankingnews.com - May 19 at 12:52 AM
	KeyCorp Comments on Innospec's Q2 2018 Earnings (IOSP) www.americanbankingnews.com - May 18 at 7:30 AM
	Q4 2018 Earnings Estimate for Innospec (IOSP) Issued By KeyCorp www.americanbankingnews.com - May 17 at 8:21 AM
	Philip Curran Sells 2,000 Shares of Innospec (IOSP) Stock www.americanbankingnews.com - May 15 at 4:18 PM
	Should You Be Tempted To Sell Innospec Inc (NASDAQ:IOSP) At Its Current PE Ratio? finance.yahoo.com - May 14 at 4:30 PM
	Brokerages Expect Innospec (IOSP) Will Announce Earnings of $1.08 Per Share www.americanbankingnews.com - May 12 at 9:20 PM
	Innospec Has The Opportunity To Leverage Self-Help And Growth Markets seekingalpha.com - May 11 at 4:30 PM
	BRIEF-Innospec Reports Q1 Earnings Per Share $0.90 www.reuters.com - May 10 at 4:37 PM
	Innospec Inc. www.streetinsider.com - May 10 at 4:37 PM
	Edited Transcript of IOSP earnings conference call or presentation 9-May-18 1:00pm GMT finance.yahoo.com - May 10 at 9:41 AM
	Innospec (IOSP) to Issue Semiannual Dividend of $0.44 www.americanbankingnews.com - May 9 at 5:41 PM
	Innospec's (IOSP) CEO Patrick Williams on Q1 2018 Results - Earnings Call Transcript seekingalpha.com - May 9 at 4:31 PM
	Innospec Reports First Quarter 2018 Financial Results globenewswire.com - May 9 at 9:30 AM
	Innospec: 1Q Earnings Snapshot finance.yahoo.com - May 9 at 9:30 AM
	Innospec (IOSP) Posts Earnings Results, Beats Estimates By $0.10 EPS www.americanbankingnews.com - May 8 at 7:50 PM
	Innospec (IOSP) Given Average Rating of "Buy" by Analysts www.americanbankingnews.com - May 8 at 1:32 AM
	FMC (FMC) & Innospec (IOSP) Critical Analysis www.americanbankingnews.com - May 5 at 10:13 AM
	Innospec (IOSP) Lowered to Buy at ValuEngine www.americanbankingnews.com - May 4 at 12:24 AM
	Hawkins (HWKN) & Innospec (IOSP) Head-To-Head Analysis www.americanbankingnews.com - May 3 at 11:17 AM
	Innospec (IOSP) Set to Announce Quarterly Earnings on Tuesday www.americanbankingnews.com - May 1 at 2:08 AM
	Critical Review: The Chemours (CC) and Innospec (IOSP) www.americanbankingnews.com - April 30 at 1:21 PM
	Brokerages Anticipate Innospec (IOSP) to Announce $0.98 EPS www.americanbankingnews.com - April 25 at 9:54 AM
	Innospec (IOSP) Stock Rating Upgraded by ValuEngine www.americanbankingnews.com - April 25 at 12:58 AM
	Innospec (IOSP) Lifted to Buy at Johnson Rice www.americanbankingnews.com - April 24 at 9:28 AM
	Innospec (IOSP) Upgraded to Buy by BidaskClub www.americanbankingnews.com - April 19 at 9:58 AM
	Innospec (IOSP) Upgraded to Hold by Zacks Investment Research www.americanbankingnews.com - April 19 at 6:36 AM
	Zacks Investment Research Downgrades Innospec (IOSP) to Hold www.americanbankingnews.com - April 18 at 10:16 PM
	Innospec (IOSP) Lowered to "Strong Sell" at BidaskClub www.americanbankingnews.com - April 15 at 1:17 PM
	Innospec (IOSP) Receives Average Rating of "Hold" from Analysts www.americanbankingnews.com - April 13 at 1:41 AM
	Global Oxygen Scavengers Market Opportunities 2018: Clariant International AG., Innospec , Accepta AS, BASF SE, Baker Hughes Incorporated www.marketwatch.com - April 10 at 9:52 AM
	Innospec Schedules First Quarter 2018 Earnings Release and Conference Call finance.yahoo.com - April 10 at 9:52 AM
	Innospec (IOSP) Downgraded to Hold at Zacks Investment Research www.americanbankingnews.com - April 9 at 8:12 AM
	Analysts Anticipate Innospec (IOSP) Will Post Earnings of $0.98 Per Share www.americanbankingnews.com - April 8 at 11:19 AM
	Innospec (IOSP) Rating Lowered to Hold at Zacks Investment Research www.americanbankingnews.com - April 6 at 8:10 PM
	Analysis: Positioning to Benefit within Euronet Worldwide, Innospec, Zosano Pharma, Ardelyx, Crown Castle International, and Aldeyra Therapeutics — Research Highlights Growth, Revenue, and Consolidated Results finance.yahoo.com - April 5 at 9:00 AM
	Innospec (IOSP) Upgraded by ValuEngine to Buy www.americanbankingnews.com - April 1 at 12:08 AM
	Monness Crespi & Hardt Lowers Innospec (IOSP) to Neutral www.americanbankingnews.com - March 31 at 7:42 PM
	Innospec (IOSP) Downgraded by Zacks Investment Research to Hold www.americanbankingnews.com - March 29 at 7:58 PM
	SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Innospec Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors finance.yahoo.com - March 26 at 9:54 AM
	Form DEFA14A INNOSPEC INC. www.streetinsider.com - March 23 at 9:27 AM
	Zacks: Brokerages Anticipate Innospec Inc. (IOSP) to Post $0.98 EPS www.americanbankingnews.com - March 22 at 11:26 AM
	BRIEF-Innospec Says CEO Patrick Williams' FY 2017 Total Compensation Was $7.4 Mln Vs $6.8 Mln www.reuters.com - March 22 at 9:43 AM
	Innospec Inc. (IOSP) Receives Consensus Rating of "Hold" from Analysts www.americanbankingnews.com - March 19 at 1:34 AM
	Innospec Inc. (IOSP) VP Philip John Boon Sells 3,558 Shares www.americanbankingnews.com - March 16 at 1:19 PM
	Innospec (IOSP) Raised to Hold at BidaskClub www.americanbankingnews.com - March 11 at 12:16 AM

Innospec (NASDAQ:IOSP) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Innospec (NASDAQ:IOSP) Income Statement, Balance Sheet and Cash Flow Statement

Innospec (NASDAQ IOSP) Stock Chart for Friday, May, 25, 2018

Loading chart…

This page was last updated on 5/25/2018 by MarketBeat.com Staff